India Pharmaceutical Export Promotion Council (PHARMEXCIL) renewed its commitment to strengthening relations between India and the United Arab Emirates (UAE) in the pharmaceutical industry. Recent talks with UAE representatives and India's proactive engagement at Arab Health 2025 emphasize this partnership vision.

Key Highlights:
Strategic Conversations:

• PHARMEXCIL Director General Raja Bhanu and Advisor AVPS Chakravarthi called on Aref Ali Alnuaimi, UAE Consul General in Hyderabad.

• Emphasize strengthening economic and trade relationships through exports of pharmaceuticals, drug discovery, vaccines, formulations, and APIs.

India Pavilion at Arab Health 2025:

• PHARMEXCIL to organize the India Pavilion at Arab Health 2025 from January 27-30, 2025, at the World Trade Center (WTC), Dubai.

• The Pavilion will have representation by 65 of India's leading pharmaceutical companies.

• Inaugurated by Satish Kumar Siven, Consul General of India to the UAE, on January 27, 2025.

Highlighting India's Pharmaceutical Capability:

• The Pavilion shall be used as a vehicle to promote Indian pharma companies to showcase their production strengths and innovative products.

• Focused on generating new business and enhancing interaction with UAE stakeholders.

Invitation to Stakeholders:
PHARMEXCIL is welcoming healthcare sector stakeholders to visit the India Pavilion and unearth the immense Indian pharma potential for the UAE market.

Quotes from Leaders:
Raja Bhanu, Director General, PHARMEXCIL
"Our partnership with the UAE is a reflection of the strong economic and commercial relationship between our countries. Exhibitions such as Arab Health 2025 further cement India's position as a pharmaceutical innovation leader."The India Pavilion at Arab Health 2025 will serve as a milestone towards enhancing the India-UAE collaboration in the pharmaceutical industry, propelling innovation and promoting bilateral growth in healthcare.